DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

H.C. Wainwright Reiterates Neutral on Sunesis Pharmaceuticals, Raises Price Target to $1

H.C. Wainwright analyst Andrew Fein reiterates Sunesis Pharmaceuticals (NASDAQ:SNSS) with a Neutral and raises the price target from $0.5 to $1.

Benzinga · 03/11/2020 12:03

H.C. Wainwright analyst Andrew Fein reiterates Sunesis Pharmaceuticals (NASDAQ:SNSS) with a Neutral and raises the price target from $0.5 to $1.